-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s108.pdf
October 01, 2007 - ORIGINAL ARTICLE
A Simulation-Based Evaluation of Methods to Estimate
the Impact of an Adverse Event on Hospital Length of Stay
Matthew H. Samore, MD,*†‡ Shuying Shen, MS,*†‡ Tom Greene, PhD,*†‡ Greg Stoddard, MPH,*†‡
Brian Sauer, PhD,*†‡ Judith Shinogle, PhD,¶ Jonathan Nebeker, MD, MS,*†‡
and Stephan Harbarth, MD, …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ongoing-studies-evidence_research.pdf
December 01, 2010 - in September 2008; and adverse events reporting in September
2009. … The National Institute of Health’s Research Portfolio Online Reporting Tool
(RePORTER) database was … We expect time
frames after those selected for this project to offer improved reporting of ongoing studies … Systematic review of the empirical evidence
of study publication bias and outcome
reporting bias. … The National Institutes of Health maintains the Research Portfolio Online Reporting Tools
(RePORT)
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
January 01, 2016 - Outcomes DA
Table F-1. Outcomes evidence table
Author, Year KQ Airway Type
Intervention 1 Device Name/Description
Intervention 1 N Analyzed
Intervention 1 Airway Type
Intervention 2 Device Name/Description
Intervention 2 N Analyzed
Intervention 2 Outcome Category Outcome Detail Analysis Modifier Category
(KQ4 Only) M…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
January 01, 2011 - Meeting Summary
AHRQ Community Forum
Page | 1
Supporting Patient and Consumer Involvement
in Patient Centered Outcomes Research
Meeting Summary
Agency for Healthcare Research and Quality
Community Forum
Wednesday, July 13, 2011
On July 13, 2011, the Agency for Healthcare Research and Quality’s (A…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_executive.pdf
June 01, 2015 - For harms (Key Question 4), we included studies
reporting complications or adverse effects related to … with allocated treatments; the
use of intent-to-treat analysis; and avoidance of selective
outcomes reporting … They have a serious or fatal flaw or combination
of flaws in design, analysis, or reporting; large amounts … and size of
studies and confidence intervals for the estimates (graded
precise or imprecise); and reporting … Other limitations of the evidence base include poor or
suboptimal reporting of harms, little evidence
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/fecal-incontinence_research-protocol.pdf
November 30, 2014 - bias,43 will be evaluated by
the potential for publication bias, selective outcome reporting bias, … and selective analysis
reporting bias by comparing reported results with those mentioned in the methods … Reporting bias will be rated as detected or not detected. … Is there suggestion
of selective outcome
reporting? … Yes Partial reporting of prespecified
outcomes (e.g., secondary not primary
outcomes; only significant
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
October 01, 2009 - What is the
evidence of benefit on other outcomes such as
symptom reporting, hospitalization, revascularization … What is the evidence of benefit on other outcomes such
as symptom reporting, hospitalization,
revascularization … What is the evidence
of benefit on other outcomes such as symptom
reporting, hospitalization, revascularization … Symptom reporting Moderate • ACE inhibitor (zofenopril) therapy increases the
time to onset of ischemic … Symptom reporting Insufficient • No data are available comparing ACE inhibitor or
ARB therapy to placebo
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/glaucoma_screening-apendices-11-5-10.pdf
December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening
APPENDIX A FDA STATUS- SCREENING DEVICES
SE: Substantially equivalent; Premarket notification, 501(k)
Page 1 of 19
Ophthalmoscope, AC-powered
Product code: HLI
COMPANY PRODUCT FDA STATUS* APPROVAL DATE
ACCUTECH MEDICAL TECHNOLOGIES IN…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-screening-apendices-11-5-10.pdf
December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening
APPENDIX A FDA STATUS- SCREENING DEVICES
SE: Substantially equivalent; Premarket notification, 501(k)
Page 1 of 19
Ophthalmoscope, AC-powered
Product code: HLI
COMPANY PRODUCT FDA STATUS* APPROVAL DATE
ACCUTECH MEDICAL TECHNOLOGIES IN…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
September 13, 2006 - Slide 1
Marketing “evidence” to healthcare consumers: Applying social marketing to evidence about the harms and benefits of pharmaceuticals
Presented by
W. Douglas Evans, Ph.D.
Lauren McCormack, Ph.D., M.S.P.H
Presented at
Agency for Healthcare Research and Quality Conference:
Communicating Harms and Benefits of
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
December 01, 2009 - Effective
Health Care
2
The American College of Radiology has created a
standardized system for reporting … the results of
mammography, the Breast Imaging Reporting and Data
System (BI-RADS®). … Due to the poor reporting and low
internal validity of the included studies, we are
concerned that the … The poor
reporting made it difficult to determine whether or not
the studies were likely to be affected … However, the available studies suffered from
poor reporting of important details that would help to
identify
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pelvic-pain_executive.pdf
January 01, 2012 - Reporting only
the harms represented in the selected studies meeting
our criteria for addressing surgical … Reporting of harms
data was very limited among trials; among placebo-
controlled trials, harms were more … among the active agents investigated, with the
exception of a placebo-controlled trial of
raloxifene reporting … Among
studies reporting data on the prevalence of
comorbidities, the range of prevalence estimates tended … are lacking
across the literature; study populations are likely to vary
widely, and studies may be reporting
-
effectivehealthcare-admin.ahrq.gov/products/benefits-harms-modeling/research
November 01, 2017 - considerations is relevant here, many of which stem from fundamental shortcomings in the design, conduct, and reporting … of diagnostic accuracy studies. 34 The STAndards for the Reporting of Diagnostic accuracy studies ( … STARD) initiative published a 25-item checklist that aims to improve reporting of studies of diagnostic … The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. … Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
February 23, 2012 - Quality improvement strategies aimed at public reporting, payment bundling, and
medication adherence … interventions that are covered by other reports within the
series (e.g., studies that target public reporting … generation, allocation concealment, blinding, incomplete outcome
data addressed, and freedom from selective reporting … , assessment of outcome, adequate duration of followup, and
adequate followup of the cohort (i.e. reporting … Series EPC Topics
Healthcare-associated infections
Medication adherence
Public reporting
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s131.pdf
October 01, 2007 - ORIGINAL ARTICLE
Increasing Levels of Restriction in Pharmacoepidemiologic
Database Studies of Elderly and Comparison With
Randomized Trial Results
Sebastian Schneeweiss, MD, ScD,* Amanda R. Patrick, MS,* Til Stürmer, MD, MPH,*
M. Alan Brookhart, PhD,* Jerry Avorn, MD,* Malcolm Maclure, ScD,*
Kenneth J. Rothman, DM…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-g.xlsx
January 01, 2022 - Design
Appendix G. Key Question 1 Full Extractions
Table G-1. Key Question 1: Design and baselines
PMID First Author Publication Year Extractor Study Directionality Study Years (e.g. 1990-1997) Country Age, Mean (SD) or Median (IQR) Age Range (e.g., 7-17) Male, N (%) Race: White, N (%) Race: Black/African American, …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-options-summarizing.ppt
June 01, 2012 - PowerPoint Presentation
Options for Summarizing
Medical Test Performance
in the Absence of a “Gold Standard”
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Options for Summarizing Medical Test Performance in the Absence of a …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-options-summarizing.ppt
June 01, 2012 - PowerPoint Presentation
Options for Summarizing
Medical Test Performance
in the Absence of a “Gold Standard”
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Options for Summarizing Medical Test Performance in the Absence of a …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-appendixes-a-f.pdf
April 29, 2024 - Appendixes A-F: Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review
A-1
Appendix A. Literature Search Strategies
Ovid MEDLINE(R) ALL 1946 to April 26, 2024
1 Dietary Carbohydrates/ or Dietary Sugars/ or Starch/
2 "Diet, Carbohydrate-Restricted"/
3 Recommende…